Content about New Jersey

April 10, 2013

New OxiClean 2in1 boosts stain-fighting detergent

OxiClean, a trademark of Church and Dwight, has launched a new 2-in-1 laundry booster designed to clean tough stains and help protect the intensity of colors.

EWING, N.J. — OxiClean, a trademark of Church and Dwight, has launched a new 2-in-1 laundry booster designed to clean tough stains and help protect the intensity of colors.

April 9, 2013

Dr. Reddy's to move North America headquarters

Generic drug maker Dr. Reddy's Labs will move into a new North America headquarters and set up new laboratory space later this year, the company said Tuesday.

HYDERABAD, India — Generic drug maker Dr. Reddy's Labs will move into a new North America headquarters and set up new laboratory space later this year, the company said Tuesday.

The India-based company said it had entered into two lease agreements for a new headquarters and research-and-development center in Princeton, N.J. These include a 75,500-sq.-ft. office space at 107 College Rd East and a 31,000-sq.-ft. office and laboratory at 303 College Rd East.

April 8, 2013

Air Wick launches national parks-inspired air fresheners

In recognition of National Park Week April 20 to 28, Reckitt Benckiser's Air Wick is launching a new line of air fresheners inspired by the essence of America's national parks. Proceeds will help benefit the National Parks Foundation.

PARSIPPANY, N.J. — In recognition of National Park Week April 20 to 28, Reckitt Benckiser's Air Wick is launching a new line of air fresheners inspired by the essence of America's national parks. Proceeds will help benefit the National Parks Foundation.

April 8, 2013

Clear Men Scalp Therapy teams up with Tony Gonzalez during March Madness

Former Division I basketball player and all-pro tight end Tony Gonzalez is teaming up with Clear Men Scalp Therapy to share his tips on executing the Perfect Play during March Madness this year.

ENGLEWOOD CLIFFS, N.J. — Former Division I basketball player and all-pro tight end Tony Gonzalez is teaming up with Clear Men Scalp Therapy to share his tips on executing the Perfect Play during March Madness this year.

April 8, 2013

Shift to Managed Medicaid shows some effects on patient care, but overall effect unclear, study finds

A growing number of patients on Medicaid are filling their prescriptions through Managed Medicaid plans instead of the fee-for-service model as states switch them over in an effort to improve patient care and cut healthcare costs, but the effects remain unclear, according to a new study.

PARSIPPANY, N.J. — A growing number of patients on Medicaid are filling their prescriptions through Managed Medicaid plans instead of the fee-for-service model as states switch them over in an effort to improve patient care and cut healthcare costs, but the effects remain unclear, according to a new study.

April 5, 2013

Actavis to market, distribute authorized generic version of Valeant drug; Valeant to co-promote Actavis drug

Actavis will market and distribute an authorized generic version of a genital herpes ointment made by Valeant Pharmaceuticals International, the companies said Friday.

PARSIPPANY, N.J. — Actavis will market and distribute an authorized generic version of a genital herpes ointment made by Valeant Pharmaceuticals International, the companies said Friday.

The agreement centers around Zovirax, known generically as acyclovir, in the 5% strength. The Food and Drug Administration approved the generic version, made by Mylan, on Wednesday. Financial terms of the deal were not disclosed.

April 5, 2013

Advil Relief in Action to support both Habitat for Humanity and Wounded Warrior Project

Pfizer Consumer Healthcare on Thursday launched its Advil Relief in Action campaign in support of both Habitat for Humanity and Wounded Warrior Project.

MADISON, N.J. — Pfizer Consumer Healthcare on Thursday launched its Advil Relief in Action campaign in support of both Habitat for Humanity and Wounded Warrior Project.

Beginning May 1, a portion of the price of participating Advil bottles will go to Habitat for Humanity International and Wounded Warrior Project. The Advil Relief in Action program will also be on-site at Habitat for Humanity builds and in conjunction with Wounded Warrior Project at Tough Mudder events.

April 4, 2013

Triscuit updates product line with Brown Rice crackers

Triscuit announced a new line of crackers that adds brown rice to its traditional wheat cracker.

EAST HANOVER, N.J. — Triscuit announced this week a new line of crackers that adds brown rice to its traditional wheat cracker.

New Brown Rice Triscuit crackers are made with 100% whole grain brown rice and wheat, and pieces of sweet potato and red beans mixed in. Brown Rice Triscuit crackers contain 21 g of whole grain per 29 g serving. The new line of crackers does not contain high fructose corn syrup, hydrogenated oil, cholesterol or artificial flavors.

Brown Rice Triscuit crackers are available in five flavors:

April 3, 2013

Basketball All-Star Lisa Leslie joins Chattem on 'Allegra Outdoor Challenge'

Basketball All-Star Lisa Leslie and Chattem created the "Allegra Outdoor Challenge," a series of workout tips to help inspire people to stay active outdoors during spring allergy season.

BRIDGEWATER, N.J. — Basketball All-Star Lisa Leslie and Chattem last week created the "Allegra Outdoor Challenge," a series of workout tips to help inspire people to stay active outdoors during spring allergy season.

Beginning in April, Allegra's Facebook page will highlight photos and tips from Leslie detailing ways families can take the "Allegra Outdoor Challenge" and escape allergy madness this spring.

April 3, 2013

Clipix launches new Web service to help simplify information aggregation

Clipix, a new free Web service launched last month, combines online bookmarking with file sharing and organization into one tool. Users now have a single service solution for saving Web content, uploading and sharing photos, and organizing documents all in one completely private or shareable space.

FORT LEE, N.J. — Clipix, a new free Web service launched last month, combines online bookmarking with file sharing and organization into one tool. Users now have a single service solution for saving Web content, uploading and sharing photos, and organizing documents all in one completely private or shareable space. Users can go to Clipix.com, drag and drop a "clip" button onto their browser bar, and then click whenever they find an item that they want to reference later. Clipix is accessible online and as a cross-mobile application on iPhone and Android devices.

April 3, 2013

FDA approves new allergy drug for children

The Food and Drug Administration has approved a new drug for allergies in children made by Tris Pharma, the drug maker said.

MONMOUTH JUNCTION, N.J. — The Food and Drug Administration has approved a new drug for allergies in children made by Tris Pharma, the drug maker said Wednesday.

Tris announced the approval of Karbinal ER (carbinoxamine maleate) extended-release oral suspension in the 4 mg-per-five milliliter strength. The company said the drug was the first sustained-release histamine receptor blocking agent for seasonal and perennial allergic rhinitis in children 2 and older.

April 2, 2013

Federal court rules in favor of Actavis in generic asthma drug case

A court has ruled in favor of generic drug maker Actavis concerning its generic version of a drug to treat asthma in children, the company said.

PARSIPPANY, N.J. — A court has ruled in favor of generic drug maker Actavis concerning its generic version of a drug to treat asthma in children, the company said.

April 2, 2013

Patients undergoing chemotherapy can find relief with the Natural Dentist

The Natural Dentist has launched “Rinse for Relief,” an online resource for proper oral care aimed at cancer patients suffering from mouth sores and other oral ailments, the fourth most common side effect of chemotherapy treatments.

MADISON, N.J. — The Natural Dentist has launched “Rinse for Relief,” an online resource for proper oral care aimed at cancer patients suffering from mouth sores and other oral ailments, the fourth most common side effect of chemotherapy treatments. The initiative included the unveiling of RinseForRelief.com and a giveaway of one free sample of Healthy Gums Mouth Rinse, an all-natural product that works as an effective daily cleanser and helps prevent and reduce gum bleeding and inflammation.

April 1, 2013

Actavis seeks approval for additional strength of generic testosterone gel

Just a week after the Supreme Court heard the Federal Trade Commission's lawsuit over its deal with AbbVie to sell a generic version of a testosterone-replacement therapy, Actavis is challenging the patent on another strength of the drug.

PARSIPPANY, N.J. — Just a week after the Supreme Court heard the Federal Trade Commission's lawsuit over its deal with AbbVie to sell a generic version of a testosterone-replacement therapy, Actavis is challenging the patent on another strength of the drug.

Actavis said Monday that it had filed with the Food and Drug Administration for approval of testosterone gel in the 1.62% strength. The drug is a generic version of AbbVie's AndroGel 1.62%. The case that went before the Supreme Court on March 25 concerns the 1% strength of AndroGel.

April 1, 2013

GSK Consumer Healthcare commends FDA nicotine replacement therapy proposals

GlaxoSmithKline Consumer Healthcare today commended the proposals by the U.S. Food and Drug Administration after the administration announced recommendations to remove certain warning statements and modifications of the instructions for use of nicotine replacement therapy products.

PARSIPPANY, N.J. — GlaxoSmithKline Consumer Healthcare today commended the proposals by the U.S. Food and Drug Administration after the administration announced recommendations to remove certain warning statements and modifications of the instructions for use of nicotine replacement therapy products.

According to the statement released by GSK Consumer Healthcare:

April 1, 2013

Lifestyles launches new Turbo condoms

The makers of LifeStyles condoms today announced the release of the new Turbo condom. The Turbo condom is lubricated inside and out with LifeStyles' proprietary Excite gel.

ISELIN, N.J. — The makers of LifeStyles condoms today announced the release of the new Turbo condom. The Turbo condom is lubricated inside and out with LifeStyles' proprietary Excite gel.

March 29, 2013

Pinnacle Foods rings NYSE Opening Bell to celebrate first day as public company

Parsippany, N.J.-based Pinnacle Foods — manufacturer and distributor of such food brands as Birds Eye, Duncan Hines, Vlasic, Mrs. Butterworth’s and others — opened for trading Thursday on the New York Stock Exchange under the ticker symbol “PF” after its initial public offering.

NEW YORK — Parsippany, N.J.-based Pinnacle Foods — manufacturer and distributor of such food brands as Birds Eye, Duncan Hines, Vlasic, Mrs. Butterworth’s and others — opened for trading Thursday on the New York Stock Exchange under the ticker symbol “PF” after its initial public offering.

CEO Bob Gamgort, along with members of Pinnacle Foods’ leadership team, celebrated the company’s first day of trading by ringing the NYSE Opening Bell and visiting the trading floor to observe the stock opening.

March 27, 2013

FDA approves Aciphex Sprinkle capsules

The Food and Drug Administration has approved a treatment made by Eisai for gastroesophageal reflux disease in children ages 1 year to 11 years, the drug maker said.

WOODCLIFF LAKE, N.J. — The Food and Drug Administration has approved a treatment made by Eisai for gastroesophageal reflux disease in children ages 1 year to 11 years, the drug maker said.

Eisai announced the approval of Aciphex Sprinkle (rabeprazole sodium) delayed-release capsules.

March 27, 2013

FDA approves injectable antihistamine using BD Simplist

The Food and Drug Administration has approved a drug administered through a new line of injection devices made by BD, the company said Wednesday.

FRANKLIN LAKES, N.J. — The Food and Drug Administration has approved a drug administered through a new line of injection devices made by BD, the company said Wednesday.

BD announced the approval of diphenhydramine hydrochloride injection, an antihistamine, packaged in its recently launched Simplist pre-filled injectables, which are made by subsidiary BD Rx and designed to improve patient care and safety by decreasing the number of steps in the traditional vial and syringe injection sequence and thus reduce the potential risk of medication errors.

March 26, 2013

FDA approves Actavis drug for opioid dependence

The Food and Drug Administration has approved a drug for opioid dependence made by Actavis, the company said.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a drug for opioid dependence made by Actavis, the company said.

Actavis announced the approval of buprenorphine hydrochloride and naloxone hydrochloride dehydrate sub-lingual tablets in the 2 mg/0.5 mg and 8 mg/2 mg strengths.

The drug is a generic version of Reckitt Benckiser's Suboxone, which had sales of about $625 million in 2012, according to IMS Health.

March 25, 2013

Actavis can launch generic version of Crestor in 2016, under deal with AstraZeneca

Generic drug maker Actavis has reached a deal with AstraZeneca that will allow it to launch a version of a drug used to treat cholesterol in three years, Actavis said Monday.

PARSIPPANY, N.J. — Generic drug maker Actavis has reached a deal with AstraZeneca that will allow it to launch a version of a drug used to treat cholesterol in three years, Actavis said Monday.

Under a deal to settle a patent-infringement lawsuit, Actavis will be allowed to launch its generic version of Crestor (rosuvastatin calcium) tablets in the 5-mg, 10-mg, 20-mg and 40-mg strengths 67 days before July 8, 2016, when the drug's market exclusivity for use in children expires, at a fee of 39% of net sales to AstraZeneca.

March 25, 2013

FDA approves Novartis antibacterial treatment for cystic fibrosis

The Food and Drug Administration has approved a treatment for managing a type of bacterial infection in patients with cystic fibrosis.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a treatment for managing a type of bacterial infection in patients with cystic fibrosis.

Swiss drug maker Novartis announced the approval of Tobi Podhaler (tobramycin inhalation powder) for managing cystic fibrosis patients with Pseudomonas aeruginosa, or Pa bacteria, in the lungs.

March 20, 2013

Retailers say 'hello' to new oral care line

Say "hello" to Hello, a new line of oral care products hitting retail shelves this month.

MONTCLAIR, N.J. — Say "hello" to Hello, a new line of oral care products hitting retail shelves this month.

The new Hello line is comprised of 99% natural toothpaste, mouthwash and breath sprays. Hello debuts in distinctive designs created by BMW Group DesignworksUSA, a subsidiary of BMW Group, and offers a departure from the traditional bottles and tubes.

March 20, 2013

Sandoz launches generic contraceptives

The Food and Drug Administration has approved and launched two generic contraceptives made by Sandoz, the drug maker said.

PRINCETON, N.J. — The Food and Drug Administration has approved and launched two generic contraceptives made by Sandoz, the drug maker said.

Sandoz, the generics division of Swiss drug maker Novartis, announced the approval of Estarylla (norgestimate and ethinyl estradiol tablets) and Tri-Estarylla (norgestimate and ethinyl estradiol tablets), generic versions of Johnson & Johnson's Ortho Cyclen and Ortho Tri-Cyclen, respectively. Sandoz said the launches brought the total number of oral contraceptives it has launched since the beginning of 2011 to six.

March 14, 2013

FDA approves Par generic obsessive compulsive disorder drug

The Food and Drug Administration has approved a drug for obsessive compulsive disorder made by Par Pharmaceutical Cos., the drug maker said Thursday.

WOODCLIFF LAKE, N.J. — The Food and Drug Administration has approved a drug for obsessive compulsive disorder made by Par Pharmaceutical Cos., the drug maker said Thursday.

Par announced the approval and shipment of fluvoxamine maleate extended-release capsules in the 100-mg and 150-mg strengths. The drug is a generic version of Jazz Pharmaceuticals' Luvox CR.